Prosecution Insights
Last updated: April 18, 2026
Application No. 18/850,272

Method for Preparing a Plurality of Condoms

Non-Final OA §102§103
Filed
Sep 24, 2024
Examiner
FUNK, ERICA HARTSELL
Art Unit
1741
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Reckitt Benckiser Health Limited
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
3y 0m
To Grant
83%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allow Rate
100 granted / 146 resolved
+3.5% vs TC avg
Moderate +14% lift
Without
With
+14.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
31 currently pending
Career history
177
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
67.9%
+27.9% vs TC avg
§102
22.7%
-17.3% vs TC avg
§112
8.0%
-32.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 146 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restriction Applicant's election without traverse of Group l: Claims 1-8 and 10-12 in the reply filed on 3/13/2026 is acknowledged. Claim 9 drawn to the non-elected group is withdrawn. IDS The IDS entered 09/24/2024 has been considered by the examiner. Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-3 and 10-11 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Thiyagarajan of record (US 20210189106 A1). Regarding claim 1, Thiyagarajan teaches compounding one or more compositions comprising natural rubber latex to make a first batch of compounded latex (P0005-6, P0020); compounding one or more compositions comprising natural rubber latex to make a second batch of compounded latex (P0020); dipping a plurality of formers into the first batch of compounded latex to form a plurality of condoms and then dipping said plurality of formers into the second batch of compounded latex to form a plurality of condoms (P0056); wherein each of the one or more compositions comprising natural rubber latex, which are used to make the first and second batch of compounded latex, has a zinc content less than 60 ppm (Tables 3-6, batches contain no zinc and 0% is within the range of 0-60 ppm, P0067). Regarding claim 2, Thiyagarajan teaches each of the one or more compositions comprising natural rubber latex has a zinc content less than 50 ppm (Tables 3-6, batches contain no zinc and 0% is within the range of 0-50 ppm, P0067). Regarding claim 3, Thiyagarajan teaches each of the one or more compositions comprising natural rubber latex is preserved with a preservative comprising zinc before compounding (P0042, P0044, P0067, “ zinc dibutyldithiocarbamate (ZDBC), zinc diethydithiocarbamate (ZDEC), zinc dimethyldithiocarbamate (ZDMC), zinc dibenzyl dithiocarbamate (ZBED), sodium diethyl dithiocarbamate (SDEC), and sodium dibutyldithiocarbamate (SDBC)”). Regarding claim 10, Thiyagarajan teaches each of the one or more compositions comprising natural rubber latex has a zinc content less than 30 ppm (Tables 3-6, batches contain no zinc and 0% is within the range of 0-30 ppm, P0067). Regarding claim 11, Thiyagarajan teaches each of the one or more compositions comprising natural rubber latex has a zinc content less than 20 ppm (Tables 3-6, batches contain no zinc and 0% is within the range of 0-20 ppm, P0067). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Thiyagarajan of record (US 20210189106 A1) as applied to claim 1. Regarding claim 7, Thiyagarajan teaches each of the plurality of condoms has a thickness of 0.1mm or less which overlaps the claimed range of from 35 to 55 μm. Overlapping ranges are prima facie evidence of obviousness. It would have been obvious to one having ordinary skill in the art to have selected the portion of Thiyagarajan 's thickness range that corresponds to the claimed range. In re Malagari, 184 USPQ 549 (CCPA 1974). Claim 4 is rejected under 35 U.S.C. 103 as being unpatentable over Thiyagarajan of record (US 20210189106 A1) as applied to claim 1 further in view of De Jong (US 20210394404 A1). Regarding claim 4, Thiyagarajan teaches compositions comprising natural rubber latex but is silent to the presence of ammonia. De Jong, in the same field of endeavor, condom production (P0045), discloses each of the one or more compositions has an ammonia content of 0.3 to 1.5 wt % (P0026) which overlaps the claimed range of from 0.65 to 1.5 wt %. Overlapping ranges are prima facie evidence of obviousness. It would have been obvious to one having ordinary skill in the art to have selected the portion of De Jong 's ammonia range that corresponds to the claimed range. In re Malagari, 184 USPQ 549 (CCPA 1974). Further, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have ammonia in this range for the purpose of adjusting the pH as taught by De Jong (P0026). Claims 5-6 and 12 are rejected under 35 U.S.C. 103 as being unpatentable over Thiyagarajan of record (US 20210189106 A1) as applied to claim 1 further in view of Kodama (US 20090105424 A1). Regarding claims 5 and 12, Thiyagarajan teaches each of the one or more compositions comprising natural rubber latex is stored for a storage period of 2 days (48 hours, P0025) but is silent to a storage period of at least 30 days before compounding or a storage period of at least 42 days before compounding. Kodama, in the same field of endeavor, latex article production (ABS), discloses a storage period of 6 months (P0156) which is fully within the claimed ranges of 30 days or more or 42 days or more. Regarding claim 6, Thiyagarajan teaches the zinc content of each of the one or more compositions comprising natural rubber latex is maintained at a level less than 60 ppm throughout said storage period (Tables 3-6, batches contain no zinc and 0% is within the range of 0-50 ppm, P0067). Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over Thiyagarajan of record (US 20210189106 A1) as applied to claim 1 further in view of Arnold (US 20140326250 A1). Regarding claim 8, Thiyagarajan teaches electronic testing of each of the plurality of condoms (P0068-70), but is silent to wherein at least 90% of the condoms of the plurality of condoms obtained by the method pass the electronic testing and all those condoms which do not pass the electronic testing are discarded. Arnold, in the same field of endeavor, condom production teaches electronic testing of each of the plurality of condoms wherein all those condoms which do not pass the electronic testing are discarded (P0049). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have tested the condoms and discarded the articles that do not pass the testing as part of standard quality control procedure as taught by Arnold (P0049). While Arnold is not specific to 90% of the condoms passing the testing, it would be obvious to optimize this value so that as few condoms as possible are discarded. Where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. It would have been obvious to one having ordinary skill in the art to have determined the optimum values of the relevant process parameters through routine experimentation in the absence of a showing of criticality. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERICA H FUNK whose telephone number is (571)272-3785. The examiner can normally be reached Monday-Friday 8:00-5:00pm ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alison Hindenlang can be reached on (571) 270-7001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ERICA HARTSELL FUNK/Examiner, Art Unit 1741
Read full office action

Prosecution Timeline

Sep 24, 2024
Application Filed
Apr 04, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594719
HIGH DENSITY MESH FOR INVERTED 3D PRINTING
2y 5m to grant Granted Apr 07, 2026
Patent 12589549
SYSTEMS AND METHODS FOR ADDITIVE MANUFACTURING
2y 5m to grant Granted Mar 31, 2026
Patent 12590001
METHOD FOR PRODUCING SUPERHYDROPHOBIC CARBON NANOTUBE SHEETS
2y 5m to grant Granted Mar 31, 2026
Patent 12585226
EXTERIOR MEMBER, CASE AND TIMEPIECE
2y 5m to grant Granted Mar 24, 2026
Patent 12583175
MOLTEN LIQUID-MARBLES AND CURTAILING AGENT FOR FORMING 3D PARTS
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
83%
With Interview (+14.4%)
3y 0m
Median Time to Grant
Low
PTA Risk
Based on 146 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month